Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Adenocarcinoma and MAP2K1[original query] |
|---|
| Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 Nov . Rekhtman N, Tafe LJ, Chaft JE, Wang L, Arcila ME, Colanta A, Moreira AL, Zakowski MF, Travis WD, Sima CS, Kris MG, Ladanyi M |
| Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Feb 18 (4): 1167-76. Rekhtman Natasha, Paik Paul K, Arcila Maria E, Tafe Laura J, Oxnard Geoffrey R, Moreira Andre L, Travis William D, Zakowski Maureen F, Kris Mark G, Ladanyi Ma |
| Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel. PloS one 2013 8 (11): e80478. Scarpa Aldo, Sikora Katarzyna, Fassan Matteo, Rachiglio Anna Maria, Cappellesso Rocco, Antonello Davide, Amato Eliana, Mafficini Andrea, Lambiase Matilde, Esposito Claudia, Bria Emilio, Simonato Francesca, Scardoni Maria, Turri Giona, Chilosi Marco, Tortora Giampaolo, Fassina Ambrogio, Normanno Nico |
| MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Apr 21 (8): 1935-43. Arcila Maria E, Drilon Alexander, Sylvester Brooke E, Lovly Christine M, Borsu Laetitia, Reva Boris, Kris Mark G, Solit David B, Ladanyi Ma |
| Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 1 21 (16): 3631-9. Drilon Alexander, Wang Lu, Arcila Maria E, Balasubramanian Sohail, Greenbowe Joel R, Ross Jeffrey S, Stephens Phil, Lipson Doron, Miller Vincent A, Kris Mark G, Ladanyi Marc, Rizvi Naiyer |
| Racial Disparities in the Molecular Landscape of Cancer. Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
| Genomic and immune profiling of pre-invasive lung adenocarcinoma. Nature communications 2019 12 10 (1): 5472. Chen Haiquan, Carrot-Zhang Jian, Zhao Yue, Hu Haichuan, Freeman Samuel S, Yu Su, Ha Gavin, Taylor Alison M, Berger Ashton C, Westlake Lindsay, Zheng Yuanting, Zhang Jiyang, Ramachandran Aruna, Zheng Qiang, Pan Yunjian, Zheng Difan, Zheng Shanbo, Cheng Chao, Kuang Muyu, Zhou Xiaoyan, Zhang Yang, Li Hang, Ye Ting, Ma Yuan, Gao Zhendong, Tao Xiaoting, Han Han, Shang Jun, Yu Ying, Bao Ding, Huang Yechao, Li Xiangnan, Zhang Yawei, Xiang Jiaqing, Sun Yihua, Li Yuan, Cherniack Andrew D, Campbell Joshua D, Shi Leming, Meyerson Matth |
| Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study. Oncotarget 2020 2 11 (5): 550-559. Aramini Beatrice, Banchelli Federico, Bettelli Stefania, Manfredini Samantha, D'Amico Roberto, Masciale Valentina, Pinelli Massimo, Moretti Margherita, Stefani Alessandro, Bertolini Federica, Dominici Massimo, Morandi Uliano, Maiorana Antoni |
| Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma. OncoTargets and therapy 2021 14 2953-2965. Wang Hao, Chen Shanhao, Meng Die, Wu Chunyan, Zhu Junjie, Jiang Minlin, Ning Jing, Wu Shengyu, Wu Lijia, Li Jingjie, Chen Bin, Zhao Sha, Li Wei, Yu Jia, Fang Qiyu, Zhu Jun, Zhao Wencheng, He Yayi, Zhou Caic |
| The diagnostic importance of pathogenic variants and variant coexistence determined by NGS-based liquid biopsy approach in patients with lung adenocarcinoma. Molecular and cellular probes 2022 5 64 101819. Cine Naci, Ali Sen Emin, Demir Gulhan, Gokbayrak Merve, Guzdolu Eda, Sertdemir Nilufer, Aydin Duygu, Kurtas Omer, Reka Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Uygun Kazim, Cabuk Devrim, Gorkem Aksu Maksut, Zafer Canturk Nuh, Savli Hak |
| The clinical value of circulating tumor DNA detection in advanced non-small cell lung cancer. Translational cancer research 2022 2 8 (1): 170-179. Lin Xiao, Dong Wentao, Lai Xiaojing, Feng Wei, Yu Xiaofu, Gu Qing, Wang Chunyang, Xiao Wen, Zheng Xi |
| Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer medicine 2023 3 . Zhao Zhiming, Li Xiaomo, Wang Fei, Xu Yong, Liu Si, Han Quanli, Yang Zhiying, Huang Weiwei, Yin Zhuzeng, Liu Qu, Tan Haidong, Ma Tonghui, Si Shuang, Huang Jia, Yuan Hongling, Li Wei, Liu Ro |
| Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers. BMC cancer 2024 8 24 (1): 951. Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina, Diego Ampuero, Liliana Ramos, Paola Pérez, Osvaldo Aren, Sara Chernilo, Cristina Fernández, María Loreto Spencer, Jacqueline Flores Aguila, Giuliano Bernal Dossetto, Mónica Ahumada Olea, Germán Rasse, Carolina Sánchez, Maria Galli de Amorim, Thais F Bartelli, Diana Noronha Nunes, Emmanuel Dias-Neto, Helano C Freitas, Ricardo Armis |
- Page last reviewed:Feb 1, 2024
- Content source: